|
Started Omnitarg(placebo)Taxotere, Herceptin trial
Yesterday was my official start in the trial they are calling "Cleopatra". It is a phase III trial, recruiting 800 patients. It must be your first treatment for metastatic breast cancer.
I either received Taxotere, Herceptin and Omnitarg or Taxotere, Herceptin and a Placebo. Treatments are every 3 weeks. They evaluate you after 3 cycles. If I am receiving Omnitarg, I will be receiving 2 out of the 3 drugs of what I like to call the "triple threat" combo that Dr. Osborn was talking about.
I will see what the scans say and then decided if I want to try to get into the DM1 trial. I told my onc about how well you girls were doing and she is very excited. She will be eligible to participate in May or June.
Kim
__________________
8/98 dx right breast
5/2003 tram flap right breast
8/2004 dx new primary left breast with inflammatory bc
er/pr-, her2neu+++
8/19 taxotere and herceptin
1/15/2005 Navelbine/Herceptin
4/2005 radiation and Herceptin
5/15/2005 Herceptin alone
2/12/2008 skin biopsy positive
2/14/2008 met to sternum, possibly right breast
2/27/08 Start omitarg, herceptin, taxotere trial
3/17/08 Kicked off trial because I started too close to my last herceptin
3/19 start tykerb xeloda
Right breast confirmed met
5/15/08 skin mets gone, no hypermetabolic activity in breast, sternum healing
8/24/08 scans still look good. sternum still active with scarring. No evidence of progression
10/08 Progression in sternum
12/08 Start TDM1 trial
1/09 Scans show stable
12/09 1 year on TDM1 still stable
10/10 progression in chest and liver
11/10 false positive of liver mets; tykerb and herceptin
4/11 Tykerb/Herceptin/Xgeva
4/11 Rads to Sternum
5/12/12 NED Herceptin/Zometa
3/16/19 still NED Herceptin/Zometa very 6months
|
Linear Mode
